Rapid ASPECTS vs StrokeViewer Perfusion
AI Verdict
Choose Rapid ASPECTS if…
Choose Rapid ASPECTS if your primary need is a fast, automated, and standardized assessment of early ischemic changes directly from non-contrast CT scans. This tool is ideal for quickly determining thrombectomy eligibility by providing an objective ASPECTS score, enhancing diagnostic accuracy and inter-reader reliability in time-sensitive stroke protocols.
View Rapid ASPECTS →Choose StrokeViewer Perfusion if…
Choose StrokeViewer Perfusion if you require comprehensive, quantitative analysis of CT perfusion scans to gain deeper insights into brain tissue viability. This tool excels at providing detailed perfusion maps, quantifying core and penumbra volumes, and assessing collateral circulation, which is crucial for nuanced treatment planning beyond initial eligibility.
View StrokeViewer Perfusion →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid ASPECTS | StrokeViewer Perfusion |
|---|---|---|
| Pricing | Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states. | Contact for pricing |
| Deployment | Software as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based). | Cloud-based; can be installed as a Docker container on standard computers or virtual platforms. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid ASPECTSRapid ASPECTS emphasizes fast results delivery (under 2 minutes) and direct integration with PACS, email, and mobile/web applications, streamlining clinician workflow. While StrokeViewer also offers mobile notifications and cloud access, Rapid ASPECTS' explicit mention of PACS integration and speed for non-contrast CT provides a slight edge in immediate clinical usability.
Clinical Value
StrokeViewer PerfusionStrokeViewer Perfusion offers a more comprehensive analysis by processing CT perfusion scans to provide quantitative brain tissue information, including core and penumbra volume, LVO detection, hemorrhage detection, and collateral circulation assessment. This provides a broader range of critical data points for complex stroke treatment decisions compared to Rapid ASPECTS' primary focus on automated ASPECTS scoring from non-contrast CT.
Pricing & Value
Rapid ASPECTSRapid ASPECTS provides a transparent starting price of approximately $12,000 for a single module in the United States, along with details on how pricing varies. In contrast, StrokeViewer Perfusion's pricing is listed as 'Contact for pricing,' making it difficult to assess its value proposition without direct inquiry.
Enterprise Readiness
Rapid ASPECTSBoth tools demonstrate strong foundational readiness with FDA clearance, HIPAA compliance, and BAA availability. However, Rapid ASPECTS' explicit mention of deployment via PACS, email, and mobile/web applications suggests a more integrated and potentially less IT-intensive solution for existing hospital infrastructures.
Innovation
StrokeViewer PerfusionStrokeViewer Perfusion showcases greater innovation by leveraging AI for comprehensive CT perfusion analysis, including advanced metrics like core/penumbra quantification, LVO detection, hemorrhage detection, and collateral assessment. This provides a more in-depth and nuanced understanding of stroke pathology beyond automated ASPECTS scoring.
Support & Docs
TieBoth RapidAI and NICo-Lab B.V. (for StrokeViewer) indicate that they offer customer support and resources like training and documentation on their websites. However, without specific comparative details on the breadth, responsiveness, or quality of these offerings, it is not possible to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid ASPECTS | StrokeViewer Perfusion |
|---|---|---|
| Name | Rapid ASPECTS | StrokeViewer Perfusion |
| Company | RapidAI | NICo-Lab B.V. |
| Primary Focus | Automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility. | AI-powered image processing software that analyzes CT perfusion scans to provide quantitative brain tissue information for suspected ischemic stroke patients, aiding in rapid diagnosis and treatment decisions. |
| ASPECTS Scoring | Automated ASPECTS score generation for non-contrast CT scans | ASPECTS scoring |
| Perfusion Analysis | Not specified | AI-powered CT Perfusion analysis; Quantitative perfusion maps (TMax, CBF, CBV); Lesion map for core and penumbra volume quantification |
| Large Vessel Occlusion (LVO) Detection | Not specified | Large Vessel Occlusion (LVO) detection |
Videos
Demos, reviews, and walkthroughs featuring Rapid ASPECTS and StrokeViewer Perfusion.